Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_assertion type Assertion NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_head.
- NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_assertion description "[rhAPC treatment also improved LPS-induced endothelial dysfunction; this effect was associated with an increase in the phosphorylated form of endothelial nitric oxide synthase and protein kinase B as well as cyclooxygenase vasodilatory pathways, thus suggesting that these pathways, together with the decrease in nuclear factor-kappaB activation and inducible nitric oxide synthase expression in the vascular wall, are implicated in the endothelial effect of rhAPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_provenance.
- NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_assertion evidence source_evidence_literature NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_provenance.
- NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_assertion SIO_000772 19395546 NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_provenance.
- NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_assertion wasDerivedFrom befree-20150227 NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_provenance.
- NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_assertion wasGeneratedBy ECO_0000203 NP232686.RAy3NSpCchCkZv-e0Mto6iL70FhBAyLxAjzBlnJ6tdp0U130_provenance.